|
| Status |
Public on Jan 12, 2023 |
| Title |
Superenhancer-driven lncRNA FASRL in hepatocellular carcinoma [ChIP-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
Superenhancers drive abnormal gene expression in tumors and promote malignancy. However, the relationship between superenhancer-associated lncRNA and abnormal metabolism is unknown.
|
| |
|
| Overall design |
In this work, we aimed to investigate the specific mechanism by which superenhancer-related lncRNAs function in lipid metabolism in hepatocellular carcinoma.
|
| |
|
| Contributor(s) |
Peng L |
| Citation(s) |
36307901 |
| |
| Submission date |
Jun 21, 2022 |
| Last update date |
Jan 12, 2023 |
| Contact name |
Li Peng |
| E-mail(s) |
pengli9@mail.sysu.edu.cn
|
| Phone |
+86 20 81332402
|
| Organization name |
Sun Yat-Sen Memorial Hospital
|
| Street address |
No. 107 Yanjiang West Road
|
| City |
Guangzhou |
| ZIP/Postal code |
510120 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (1) |
|
| This SubSeries is part of SuperSeries: |
| GSE206549 |
Superenhancer-driven lncRNA FASRL in hepatocellular carcinoma |
|
| Relations |
| BioProject |
PRJNA851365 |
